NPCE
Neuropace Inc
14.30$
+0.9%
vs. previous close
Closing price · As of: Sep 18, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 28.4% | 26.4% | 26.0% | 28.6% | 26.4% | 26.1% | 22.8% | |
| 71.6% | 73.6% | 74.0% | 71.4% | 73.6% | 73.9% | 77.2% | |
| 49.5% | 38.2% | 40.3% | 48.2% | 31.8% | 29.6% | 27.9% | |
| 81.7% | 67.2% | 86.2% | 112.8% | 83.3% | 21.8% | 19.1% | |
| 131.2% | 105.3% | 126.5% | 161.0% | 115.1% | 101.1% | 93.6% | |
| -59.6% | -31.7% | -52.5% | -89.6% | -41.5% | -27.1% | -16.3% | |
| 25.7% | 27.9% | 16.4% | 16.5% | 13.0% | 11.0% | 7.5% | |
| -81.1% | -59.0% | -79.9% | -103.4% | -50.4% | -34.0% | -21.5% | |
| 29.1% | 28.5% | 4.5% | 13.8% | 2.2% | – | – | |
| -81.1% | -59.0% | -79.9% | -103.4% | -50.4% | -34.0% | -21.5% | |
| -54.3% | -30.3% | -62.8% | -80.3% | -34.9% | -20.7% | -12.1% |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.